Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tinzaparin in advanced pancreatic cancer
NCT05178628Phase 3Unknown
- Start
- Feb 2022
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of tinzaparin in pancreatic cancer (PC). Status: unknown.
02
Drugs
tinzaparin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT05178628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05178628.